Amgen Investing More Than Half a Billion Dollars in New State-of-the-Art Center for Science and Innovation at U.S. Global Headquarters
September 02, 2025
Amgen (NASDAQ: AMGN) today announced plans to invest more than $600 million in a new, state-of-the-art center for science and innovation at its global headquarters in Thousand Oaks, California.
Research and Development Infrastructure Investment Expected to Create Hundreds of U.S. Jobs
THOUSAND OAKS, Calif.,Sept. 2, 2025/PRNewswire/ --Amgen (NASDAQ: AMGN) today announced plans to invest more than $600 million in a new, state-of-the-art center for science and innovation at its global headquarters in Thousand Oaks, California.
Read the full press release on Amgen's site.